SUMMARY
Energy production in the brain depends almost exclusively on oxidative metabolism. Neurons have small energy reserves and require a continuous supply of oxygen (O 2 ). It is therefore not surprising that one of the hallmarks of normal brain function is the tight coupling between cerebral blood flow and neuronal activity. Since capillaries are embedded in the O 2 -consuming neuropil, we have here examined whether activity-dependent dips in O 2 tension drive capillary hyperemia. In vivo analyses showed that transient dips in tissue O 2 tension elicit capillary hyperemia. Ex vivo experiments revealed that red blood cells (RBCs) themselves act as O 2 sensors that autonomously regulate their own deformability and thereby flow velocity through capillaries in response to physiological decreases in O 2 tension. This observation has broad implications for understanding how local changes in blood flow are coupled to synaptic transmission.
INTRODUCTION
Neurovascular coupling is a process in which synaptic activity is linked to local changes in cerebral blood flow (Iadecola and Nedergaard, 2007; Kleinfeld et al., 2011) . The mechanisms by which neural activity triggers hyperemia have been extensively studied because neurovascular coupling forms the basis for functional brain imaging. In addition, defects in neurovascular coupling may contribute to cognitive decline in neurodegenerative diseases, such as Alzheimer disease, as well as in hypertension and stroke (Girouard and Iadecola, 2006) . Functional hyperemia can be mediated by a number of compounds, many of which are byproducts of neural activity, including adenosine, nitric oxide (NO), prostaglandin E 2 (PGE 2 ), potassium ions (K + ), epoxyeicosatrienoic acids (EETs), and carbon dioxide (CO 2 ) (Iadecola and Nedergaard, 2007) . In addition, functional hyperemia is preceded by a transient decrease in tissue oxygenation (Devor et al., 2011; Lecoq et al., 2011; Parpaleix et al., 2013) . Since recent work has documented that functional hyperemia is initiated in microvessels embedded in the oxygen (O 2 )-consuming neuropil, we asked whether the initial dip in tissue O 2 tension drives brain capillary hyperemia.
RESULTS

Functional Hyperemia Begins in Capillaries and Is Inhibited When Oxidative Phosphorylation Is Suppressed
To identify the brain region activated by hindlimb stimulation, we first visualized the exposed cortex using intrinsic optical signaling (IOS) followed by high-speed two-photon line scanning to assess red blood cell (RBC) velocities in arterioles and capillaries in the contralateral sensory cortex of lightly sedated mice ( Figure 1A ) (Bekar et al., 2012; Takano et al., 2006) . Only cortical arterioles and capillaries located in the cortical region that exhibited the largest activity-dependent increase in IOS were analyzed. A comparison of the onset time of stimulation-induced elevation in RBC velocity revealed that capillary RBC velocities (0.67 ± 0.15 s, n = 65, 25 mice) increased prior to RBC velocities of upstream arterioles (2.33 ± 0.22 s, n = 61, 25 mice) ( Figure 1B) , which is consistent with conclusions drawn by a prior study on vascular diameters (Hall et al., 2014) . Additional analysis of a subset of connected capillaries and arterioles confirmed that, following hindlimb stimulation, the onset of RBC velocity increases in capillaries preceded that of upstream arterioles (Figure S1A) . In these experiments, cortical vascular trees were mapped prior to data collection and corresponding arterioles and capillaries were identified for line scanning. We also collected line scans orthogonally across vessel widths of arterioles and capillaries. These data showed that arterioles dilated at 2.38 ± 0.37 s, whereas capillary dilation occurred at 2.46 ± 0.22 s after hindlimb stimulation (n = 53-283, 15-18 mice) ( Figure 1C ). In agreement with a recent publication, a slight dilation of capillaries was noted, but this occurred concomitant with arteriole dilation and most likely reflected pressure-induced increases in blood flow and/or volume (Hill et al., 2015) . Thus, activity-dependent increases in capillary RBC velocities occur prior to both dilations of and RBC velocity increases in upstream arterioles, indicating that capillary hyperemia occurs before arterial hyperemia.
An intraparenchymal dip in partial pressure of oxygen (PO 2 ) (Yacoub et al., 2001 ) began at 0.29 ± 0.09 s after hindlimb stimulation ( Figure 1E ), similar to previous reports (Lecoq et al., 2011; Parpaleix et al., 2013) , and thereby preceded capillary hyperemia by as much as 0.38 s. Could the transient dip in tissue PO 2 be responsible for the initial phase of capillary hyperemia? To test this question, we applied sodium cyanide (NaCN), a potent inhibitor of cytochrome c oxidase and thus O 2 utilization, to the exposed cerebral cortex. Initial experiments showed that 0.1 mM NaCN was the highest concentration that did not interfere with excitatory potentials evoked by hindlimb stimulation ( Figure 1D ). Applying 0.1 mM NaCN on the pial surface increased resting PO 2 (18.62 ± 2.51 mmHg PO 2 before NaCN, 38.74 ± 4.40 mmHg PO 2 after NaCN, n = 10 mice, p < 0.0001, paired t test). NaCN also significantly suppressed stimulationinduced dips in tissue PO 2 , though it did not change the onset of the evoked PO 2 dip ( Figure 1E ). NaCN reduced the amplitude of capillary hyperemia by 78% (n = 29-38, 6-13 mice, p < 0.001, t test) ( Figure 1F ), but it did not attenuate activity-evoked penetrating arteriole vasodilation or velocity increases (Figures 1G and 1H) . This observation is surprising because the release of traditional smooth muscle relaxing mediators of functional hyperemia, including adenosine and K + , is potentiated rather than inhibited when oxidative phosphorylation is suppressed (Daval et al., 1980) . The fact that NaCN application significantly suppressed capillary hyperemia alone is consistent with the idea that the activity-induced transient dip in tissue PO 2 triggers an increase in local capillary RBC velocity. A) Experimental setup for assessing functional hyperemia elicited by sensory stimulation. Arterial blood pressure was monitored through a femoral artery catheter while the other hindlimb was stimulated. Through a cranial window, intrinsic optical signaling (IOS) was used to identify the cortical region of functional hyperemia. LFP and O 2 sensor microelectrodes were placed in close proximity (10-20 mm) to one another within the activated region. During hindlimb stimulation, blood vessels in the activated contralateral hindlimb cortex were imaged using two-photon laser scanning microscopy. (B) Time-course plot of hindlimb stimulation-evoked RBC velocity changes in cortical arterioles (red) and capillaries (black). Inset: IOS imaging (shown as a pseudocolor image) was used to identify the location of the activated hindlimb cortex in all experiments. Scale bar, 300 mm. Evoked RBC velocity increases began in capillaries (0.67 ± 0.15 s) prior to arterioles (2.33 ± 0.22 s). n = 61-65, 25 mice. ***p < 0.001, t test; **p < 0.01, Mann-Whitney test. Black arrow indicates start of stimulation, black bar indicates duration of stimulation. (C) Time-course plot of diameter changes of cortical arterioles (red) and capillaries (black). Arterioles began to dilate at 2.38 ± 0.37 s and capillaries at 2.46 ± 0.22 s after hindlimb stimulation. n = 53-283, 15-18 mice. ns, p > 0.05, Mann-Whitney test. (D) Topical treatment with cyanide (100 mM) did not alter LFP power within the duration of the experiments. n = 13, 5 mice. ns, p > 0.05, paired t test. (E) Activity-dependent PO 2 dips were suppressed by cyanide (1.92 ± 0.20 mmHg PO 2 dip without NaCN, 0.67 ± 0.26 mmHg PO 2 dip with NaCN). n = 36-47, 4-21 mice. ***p < 0.001, Mann-Whitney test. Onset of the evoked PO 2 dip was unchanged by cyanide (0.29 ± 0.09 s without NaCN, 0.46 ± 0.17 s with NaCN). n = 36-47, 4-21 mice. ns, p > 0.05, Mann-Whitney test. (F) Activity-dependent increases in capillary RBC velocity was nearly abolished by cyanide (19.66% ± 3.83% without NaCN, 4.29% ± 1.20% with NaCN). n = 29-38, 6-13 mice. ***p < 0.001, t test. (G) Activity-dependent penetrating arteriole vasodilation was unaffected by cyanide (4.95% ± 0.61% without NaCN, 4.79% ± 0.61% with NaCN). n = 66-79, 13-17 mice. ns, p > 0.05, Mann-Whitney test. (H) Activity-dependent increases in cortical arteriole RBC velocity persisted in the presence of cyanide (8.22% ± 1.47% without NaCN, 8.36% ± 1.85% with NaCN). n = 35-43, 18-19 mice. ns, p > 0.05, Mann-Whitney test. Data are represented as mean ± SEM. See also Figure S1 .
PO 2 Dips Are Sufficient to Elicit Capillary Hyperemia
We next asked whether a change in tissue PO 2 , in the absence of sensory activation, is sufficient to trigger capillary hyperemia. To address this question, we separately microinjected three structurally different O 2 scavengers, sodium ascorbate, sodium sulfite, or sodium dithionite, near capillaries in the hindlimb cortex under the guidance of two-photon imaging (Figure 2A ). Ascorbate, sulfite, and dithionite all triggered a rapid decrease in local tissue PO 2 . Similar to activity-dependent responses, tissue PO 2 exhibited a bi-phasic pattern, with an initial transient dip followed by a delayed and long-lasting overshoot (Figure 2A ). Strikingly, RBC velocity increased in nearby capillaries after microinjection of O 2 scavengers, suggesting that tissue oxygenation influences capillary blood flow ( Figure 2B ). For more detailed analyses, we focused on sulfite, which is converted to the relatively nontoxic compound sulfate after reaction with O 2 . We found that increasing the concentration of sulfite triggered a dose-dependent increase in RBC velocity ( Figure 2C ). Sulfite microinjection also caused vasodilation of nearby penetrating arterioles, but the arteriolar vasodilation was delayed relative to sulfite-induced capillary velocity increases ( Figure 2D ). Microinjection of the maximal concentration of sulfite (1 M) was not associated with detectable changes in the power spectrum of local field potential (LFP) activity ( Figure 2E ). Thus, local application of O 2 scavengers alone in the absence of sensory stimulation triggered hyperemia that closely resembled activity-dependent hyperemia. Moreover, sulfite elicited capillary hyperemia in both capillaries with and without pericytes in NG2-DsRed mice, suggesting that increases in RBC velocity occurred independent of pericyte presence ( Figure 2F ). We defined capillaries with pericytes as capillaries in contact with pericyte cell bodies and capillaries without pericytes as capillaries lacking contact with pericyte (G) Left: inhibitors were topically applied to the cranial window prior to microinjection of sulfite. Right: a summary histogram of capillary RBC velocity changes induced by sulfite microinjection in the presence of the nitric oxide synthase (NOS) inhibitor L-NAME (2 mM), cyclooxygenase (COX) inhibitor indomethacin (500 mM), adenosine receptor inhibitors DPCPX and SCH 58261 (each 1 mM), K + channel inhibitor barium (100 mM), and cytochrome c oxidase inhibitor cyanide (100 mM). n = 27-47, 5-6 mice. **p < 0.01, ***p < 0.001, compared to saline, Kruskal-Wallis with Dunn's test. Data are represented as mean ± SEM. See also Figure S2 .
cell bodies. Next, we asked whether it is the depletion of O 2 that directly triggers hyperemia or whether hyperemia is induced indirectly by release of vasoactive mediators. To systematically address this, we tested whether sulfite-elicited capillary hyperemia was reduced by pretreatment with inhibitors of NO production (L-NAME), inhibitors of PGE 2 production (indomethacin), adenosine A1 and A2A receptor antagonists (DPCPX and SCH 58261), or inhibitors of inward-rectifying K + channels (barium). Topical application of these inhibitors to the pial surface all failed to suppress sulfite-induced capillary hyperemia ( Figure 2G ), indicating that PO 2 -induced capillary hyperemia is not dependent on vascular smooth muscle relaxation.
To evaluate the contribution of pericytes to capillary hyperemia, we compared the amplitude and onset time of activityinduced RBC velocity increases of capillaries in contact with pericyte cell bodies with capillaries lacking contact with pericyte cell bodies in NG2-DsRed reporter mice. The baseline capillary diameter adjacent to the cell bodies of NG2-DsRed pericytes did not differ from segments of capillaries not in contact with pericyte cell bodies ( Figure S2A ). We found that activity-evoked capillary hyperemia was unaffected by the presence or absence of an adjacent pericyte cell body. Capillary RBC velocity began at 0.71 ± 0.35 s in capillaries with pericytes (n = 28, 5 mice) and at 0.66 ± 0.22 s in capillaries without pericytes (n = 31, 5 mice) ( Figure S2B ). Next, we evaluated pericyte expression of actin in mouse cortex using phalloidin staining of F-actin as well as a-smooth muscle actin (a-SMA) immunolabeling in fixed sections. Similar to prior studies, we defined the penetrating vessel as the zeroth branch order vessel, with subsequent branches labeled using increasing branch order numbers (Hall et al., 2014; Hill et al., 2015; Kornfield and Newman, 2014) . Quantification confirmed that vessels beyond the third branch order were largely phalloidin and a-SMA negative (only 1.4% of vessels fourth order or higher, averaging 4.0 mm in diameter, were phalloidin and/or a-SMA positive, n = 49 vessels from 9 mice). In contrast, vessel branches zero to three were largely phalloidin and/or a-SMA positive (22%-100% actin positive, ranging from 5.4 to 13.3 mm in diameter, n = 12-25 vessels from 9 mice) (Figure S2C) . Only $30% of DsRed+ pericyte cell bodies along branches one to three were actin positive (Figures S2D and S2E) . These observations are in agreement with a recent study showing that smooth muscle actin is expressed by arterioles, but not capillary mural cells, in mouse and human neocortex (Hill et al., 2015) . Hill et al. also showed that unlike smooth muscle actin-positive arterioles, pericyte-covered capillaries do not constrict or dilate in response to stimulation.
An important detail for validation of our in vivo analysis was our finding that 100% of DsRed-positive cells were PDGFRb positive and conversely that 100% of PDGFRb-positive cells were DsRed positive in NG2-DsRed reporter mice ( Figure S2F ). In addition, DsRed-positive perivascular cells in NG2-DsRed reporter mice stained positively for desmin and CD13 in immunohistochemical slices ( Figure S2G ). Therefore, capillaries identified as with or without pericytes during in vivo imaging of NG2-DsRed reporter mice were properly categorized, as PDGFRb, desmin, and CD13 are pericyte-specific markers (Armulik et al., 2011) .
AMPA Receptor Activity Modulates Capillary RBC Velocity
The velocity by which RBCs pass through capillaries is highly variable (Chaigneau et al., 2003; Kleinfeld et al., 1998; Stefanovic et al., 2008) . Based on the observation of a tight coupling between postsynaptic AMPA receptor activity and tissue PO 2 (Enager et al., 2009; Mathiesen et al., 2011) , as well as our observation that NaCN inhibits both evoked PO 2 dips and capillary hyperemia ( Figure 1E and 1F) while microinjection of O 2 scavengers induces capillary hyperemia ( Figure 2B ), we asked whether the ever-changing pattern of synaptic activity contributes to spontaneous fluctuations in capillary RBC velocity.
The AMPA receptor antagonist CNQX (200 mM) was topically applied to the cerebral cortex and its effect on baseline (unstimulated) LFPs, PO 2 , and capillary RBC velocity was assessed. As a measure of baseline variability, we compared the SD of LFPs, PO 2 , and capillary RBC velocity before and after application of CNQX ( Figures 3A-3C ). As expected, CNQX potently suppressed both the power and the SD of baseline LFPs ( Figure 3A ). Baseline PO 2 levels also exhibited a significant increase (52.6% increase) and the variability of baseline PO 2 was reduced (45.0% suppression of SD by CNQX) ( Figure 3B ). Baseline capillary RBC velocity decreased by 25.7%, and interestingly, the SD of RBC velocity fluctuations also fell significantly in response to CNQX (26.7% suppression by CNQX) ( Figure 3C ), suggesting that AMPA receptor-mediated PO 2 dips in part contribute to the variability of capillary RBC velocity at rest. Prior analyses have shown that cardiac-and respiration-dependent pulsatile blood flow is also in part responsible for the high variability in baseline capillary RBC velocities (Santisakultarm et al., 2012) . Of note, baseline arterial diameter remained unchanged after addition of CNQX ( Figure 3D ). To extend the analysis to include capillary functional hyperemia, we next compared responses to hindlimb stimulation before and after addition of CNQX. As expected, CNQX produced a dramatic decrease in excitatory potentials and PO 2 dip amplitudes evoked by a 2 s hindlimb stimulation (81.0% and 90.1% suppression by CNQX, respectively) ( Figures 3E and 3F) . Consistent with the key role of AMPA receptor activation in functional hyperemia, CNQX significantly delayed the onset and suppressed the amplitude of capillary RBC velocity increases in response to hindlimb stimulation (75.0% suppression by CNQX) ( Figure 3G ). Figures 3H and 3I compare the relative power by which blockade of AMPA receptors suppressed spontaneous fluctuations and stimulation-dependent changes in LFPs, PO 2 , and capillary RBC velocity. Of note, inhibition of NMDA receptors (AP5, 500 mM) did not have a significant effect on capillary hyperemia ( Figure S3 ). This observation is consistent with the idea that excitatory transmission is primarily the result of AMPA receptor activation in the sensory cortex (Hoffmeyer et al., 2007; Self et al., 2012) .
Together, these results suggest that O 2 -consuming synaptic activity is partly responsible for the variability of cortical capillary RBC velocities during resting conditions and primarily responsible for the initiation of activity-dependent capillary hyperemia.
Oxygen Depletion Alone Is Sufficient to Increase RBC Velocity Ex Vivo
The observation that microinjection of O 2 scavengers induced pericyte-and vasoactive mediator-independent capillary hyperemia led us to hypothesize that O 2 tension itself, independent of the neurovascular unit, can control RBC deformation and thus RBC flow through capillaries. To test this idea in the absence of the neurovascular unit, we turned to an ex vivo assessment of the effect of oxygenation on RBC flow through an artificial capillary. We employed a microfluidic device in which isolated human RBCs pass through a narrow flow channel (Figure 4A) (Abkarian et al., 2006; Cinar et al., 2015; Wan et al., 2008 Wan et al., , 2011 . This approach allowed an evaluation of RBC velocity in the absence of the cellular components of the neurovascular unit, i.e., endothelial cells, pericytes, and astrocytes (Petzold and Murthy, 2011) . Since the capillary lumen is considerably smaller than RBC diameters, RBC deformability is a major determinant of the speed by which the RBC passes through a capillary (Chaigneau et al., 2003) . A microfluidic device made of polydimethylsiloxane (PDMS) was submerged in a chamber containing sodium sulfite, an O 2 scavenger. Since PDMS is O 2 , but not H 2 O, permeable the chamber functioned as a sink for O 2 ( Figure 4A) . A colorimetric calibration, based on adding the O 2 -sensing dye tris(2,2 0 -bipyridyl)dichlororuthenium(II) hexahydrate to deionized (DI) water showed that PO 2 in the flow channel was an inverse function of the sulfite concentration (0 to 2 M) (legend continued on next page) ( Figure 4B ). Remarkably, the velocity of RBCs flowing through the channel increased as a function of O 2 depletion, indicating that brief deoxygenation alone can affect the mechanical properties of RBCs (Figures 4B and 4C ). The O 2 -dependent increase in RBC velocity was observed when RBCs were resuspended in either plasma or PBS ( Figure 4C ). Because PO 2 in capillaries is highly variable and can range from $5 to 95 mmHg but tends to be on the lower end of that range within true microvessels (Kasischke et al., 2011; Parpaleix et al., 2013 ; Sakad zi c et al., 2014), we focused on the effects of relatively lower PO 2 . In these experiments, the PBS was first purged with N 2 until the PO 2 reached 34 mmHg, approximating normal brain PO 2 (Jaeger et al., 2005 ). Similar to above, RBCs were driven through a microfluidic chamber immersed in a sulfite sink (0 to 1 M) and colorimetrically calibrated ( Figure 4B ). This analysis showed that at a relatively lower range of O 2 tension, RBC velocities became more sensitive to surrounding changes in PO 2 (p < 0.001, t test with Bonferroni test, compared to PBS without N 2 purging and plasma) ( Figures  4C and 4D) . Interestingly, however, increasing the O 2 from 21% to 100% (or from PO 2 $160 mmHg to $760 mmHg) failed to alter RBC velocity in the microfluidic capillary (1.000 normalized velocity in 21% versus 0.998 normalized velocity in 100% O 2 , n = 9-19, p > 0.05, t test), consistent with the notion that at superphysiologic PO 2 , hemoglobin continues to be maximally saturated with O 2 and RBCs reach the limit of their ability to bind additional O 2 and respond with velocity changes. Classical studies have shown that in response to deoxygenation and/or mechanical stress, RBCs release ATP, which activates endothelial cell purinergic receptors (P 2 YR1s), resulting in NO release. In turn, NO or other endothelium-dependent vasodilators increase blood flow in hypoxic tissues via arterial smooth muscle relaxation (Chen et al., 2014; Ellsworth et al., 2009; Jia et al., 1996) . RBCs may also directly release NO from S-nitroso-Hb upon deoxygenation (Jensen, 2009 ). However, we found that the PO 2 -elicited increase in RBC flow velocity was not a result of direct ATP or NO release. Exposing RBCs to the ATP-degrading enzyme apyrase (40 U/mL) or the NO synthase inhibitor L-NAME (3 mM) did not affect PO 2 -induced elevations in RBC velocity ( Figure 4D ), in accordance with the in vivo observation that L-NAME failed to suppress capillary hyperemia ( Figure 2G ). In addition, CNQX had no effect on PO 2 -induced increases in RBC velocity through the microfluidic channel ( Figure 4D Figure 4E ), suggesting that K + flux across the membrane plays a role in the velocity of RBC flow in capillaries. As a negative control, RBCs were treated with diamide, which stiffens the RBC membrane by crosslinking the cytoskeletal spectrin network (Fischer et al., 1978; Wan et al., 2008) . The flow velocity of diamideexposed RBCs was unaffected by PO 2 , supporting the notion that the PO 2 -induced increase in RBC flow velocity is due to increased deformability of the RBC membrane ( Figure 4D ).
To directly test whether RBC deformability is controlled by PO 2 , we assessed the shear-induced deformability of RBCs flowing in a relatively large-sized microfluidic channel containing a segment of constriction (width = 20 mm) ( Figure 4F Forsyth et al., 2010; Mohandas et al., 1980) . We found that the elongation of RBCs in response to shear stress increased as PO 2 decreased, demonstrating that RBCs are more flexible in lower PO 2 conditions ( Figure 4G ). The dependence of RBC deformability on PO 2 was significantly diminished when diamide was added ( Figure 4G ). RBCs treated with the K + channel blockers 4-AP (1 mM), charybdotoxin (100 nM), or iberiotoxin (100 nM) also exhibited reduced sensitivity to PO 2 changes compared to controls ( Figure 4H ). These data show that lowering PO 2 increases RBC deformability and thereby the velocity by which RBCs pass through a narrow ex vivo capillary lacking endothelial cells, pericytes, and astrocytes. Exposure to K + channel inhibitors reduced the deformability of RBCs and thus the potency by which PO 2 increased RBC flow velocity. This latter observation is consistent with prior studies documenting that a decrease in cell volume mediated by K + efflux and water loss may play a role in permitting RBC deformation during the shear stress associated with squeezing through a narrow capillary (Cinar et al., 2015) .
Exchanging RBCs for an O 2 -Carrying Blood Substitute Suppresses Functional Hyperemia In Vivo
Our ex vivo data suggest that RBCs autonomously regulate their own velocities through capillaries in response to changes in surrounding PO 2 tension. If this finding is relevant in vivo, we would expect that in vivo capillary hyperemia is suppressed when RBCs are replaced by an acellular hemoglobin-based O 2 carrier (HBOC). To meticulously test whether RBCs are required for activity-dependent capillary hyperemia, we partially exchanged the blood in our mouse model with a synthetic HBOC, i.e., polymerized hemoglobin (PolyHb) (Baek et al., 2012; Zhou et al., 2011) . We were able to decrease the hematocrit by 80.3% ± 0.5% (10.55 ± 0.11 3 10 6 versus 2.08 ± 0.046 3 10 6 cells per mL) by gradually replacing RBCs with PolyHb. Mixing PolyHb with whole blood did not alter blood viscosity ( Figure 5A ). PolyHb blood exchange did not alter resting cortical PO 2 , sensoryinduced dips in PO 2 ( Figure 5B ), or sensory-evoked electrical activity (evoked LFP 10 Hz power was 0.017 ± 0.0085 mV 2 in control mice and 0.015 ± 0.0064 mV 2 in PolyHb mice, p > 0.05, t test).
It did, however, delay the onset time and reduce the amplitude of activity-dependent capillary hyperemia ( Figures 5C and 5D ). Basal cortical arteriole diameters were unchanged but evoked arteriole vasodilation was reduced with PolyHb ( Figure 5E ). With an insufficient RBC population, capillary hyperemia may be primarily driven by upstream arteriole vasodilation. How does hyperoxygenation affect the microcirculation? Breathing 100% O 2 elevated baseline cortical PO 2 from $25 to $50 mmHg (Jaeger et al., 2005) without causing significant changes in the evoked PO 2 dip ( Figure 5F ). Basal capillary RBC velocities were reduced while basal arteriole diameters and capillary hyperemia were unchanged ( Figures 5G and 5H) . Hence, both the ex vivo and in vivo observations provide strong support for the notion that deoxygenation-mediated changes in erythrocyte deformability drive capillary hyperemia.
DISCUSSION
Despite the uncontested tight linkage between neural activity and vascular responses, the question of what drives functional hyperemia is still debated. In principle, a mechanism sensing depletion of an energy substrate (O 2 or glucose) or alternatively the release of vasoactive mediators (NO, PGE 2 , ATP, adenosine, K + , and other molecules) could drive activity-dependent increases in blood flow. In this work, we took advantage of the discovery that functional hyperemia is initiated in microvessels rather than in arterioles (Hall et al., 2014) . We confirmed that capillary RBC velocity increases 1-2 s prior to arterial hyperemia but similar to a recent study (Hill et al., 2015) failed to identify pericytes as the principal regulator of capillary hyperemia. Several experimental findings presented here implicate the transient PO 2 dip in the initiation of the activity-dependent increase in capillary perfusion via a mechanism independent of the release of vasoactive agents and smooth muscle relaxation, including: (1) capillary functional hyperemia was suppressed when oxidative metabolism was inhibited by local application of NaCN. Not only does this observation support the notion that PO 2 regulates capillary perfusion, but it also indirectly provides evidence against a central role of vasoactive mediators in initiating functional hyperemia, since adenosine, lactate, and K + release are all increased when oxidative metabolism is inhibited (Daval et al., 1980) . (2) The effect of PO 2 on RBC deformability is debated, possibly because most past studies were based on indirect measurements that have not been readily reproducible (Kim et al., 2015; Martindale and McKay, 1995; Yoon et al., 2009 ). To our knowledge, no prior studies have directly quantified changes in RBC velocity and deformability in response to transient changes in PO 2 . The data presented here using an ex vivo microfluidic approach demonstrate a direct relationship between RBC velocity and deformability elicited by transient decreases in PO 2 .
Deoxygenation of RBCs leads to displacement of ankyrin from band 3, resulting in release of the spectrin/actin cytoskeleton from the cell membrane (Stefanovic et al., 2013) . The weakening of membrane-cytoskeletal interactions has been proposed to be beneficial to blood flow during brief periods of deoxygenation (Stefanovic et al., 2013) and may contribute to increased RBC deformability during drops in PO 2 . Prior studies in peripheral tissues have shown that RBCs can induce hyperemia but pointed to a mechanism that involves ATP release from RBCs (under shear-induced deformation and/or hypoxia), which triggers endothelial cell NO production that subsequently dilates arteries by hyperpolarizing vascular smooth muscle cells (Ellsworth et al., 2009) . Our microfluidic chamber experiments showing that lowering PO 2 in the absence of the neurovascular unit increased isolated RBC velocity, coupled with the finding that L-NAME (an inhibitor of NO synthase) had no effect on capillary hyperemia, argue against a significant contribution from this paracellular signaling mechanism. Furthermore, PO 2 -induced arteriole dilation was delayed relative to PO 2 -induced capillary blood flow increases, mimicking hyperemia elicited by sensory input and signifying that arteriole vasodilation is not the primary driver of PO 2 -dependent capillary hyperemia. Previously, the existence of an O 2 -sensing mechanism has been questioned based on the finding that regional functional hyperemia persisted in hyperbaric hyperoxia (Lindauer et al., 2010) . We here confirmed that capillary hyperemia was preserved in hyperoxia but extended the analysis to show that activity-induced PO 2 dips persisted during hyperoxic conditions. Thus, hyperoxia did not suppress either activity-induced PO 2 dips or capillary hyperemia. Additionally, inhibiting metabolic O 2 consumption by application of cyanide blocked both activity-dependent dips in PO 2 and capillary hyperemia irrespective of the baseline tissue PO 2 . Collectively, these sets of data suggest that it is the transient PO 2 dip rather than baseline PO 2 that triggers capillary hyperemia. This conclusion is further supported by our ex vivo observation that RBC velocity in the microfluidic device increased in response to PO 2 reductions across a wide range of physiological PO 2 levels (0-160 mmHg).
It is important to note that functional hyperemia outlasted the dip in PO 2 . Accordingly, only the very initial phase (<1.5 s) of capillary hyperemia that precedes arterial dilation is driven by activity-induced dips in PO 2 . The initial capillary response during functional hyperemia may serve as the rapid phase of hyperemia that supplies active neurons with immediately available O 2 . The delayed and sustained hyperemic phase is most likely powered by the slower dilation of upstream arterioles and serves to prevent a prolonged drop in oxygenation at tissue located more remotely from arterioles and proximal capillaries (Devor et al., 2011; Leithner and Royl, 2014) . It is unclear whether PO 2 -mediated rapid capillary hyperemia directly causes delayed arteriole vasodilation, as it has been shown that release of vasoactive agents from both interneurons and astrocytes can trigger arteriole dilation (Cauli and Hamel, 2010; Takano et al., 2006) . Capillary hyperemia and arteriole hyperemia may have independent regulatory mechanisms that work in a concerted manner to optimize blood supply. Alternatively, the delayed dilation of upstream arterioles may be a consequence of PO 2 -induced rapid capillary hyperemia, mediated by the propagation of Ca 2+ signals along the neurovascular unit ( Figure 6 ). If so, it is interesting to speculate whether the impaired vasoreactivity observed in various diseases and in aging is a consequence of impaired PO 2 -mediated capillary hyperemia. Future studies can address the relationship between capillary hyperemia and delayed arteriole dilation. Further experiments can also assess sensoryevoked capillary hyperemia in awake behaving mice.
Functional hyperemia is an integrated response that tightly couples O 2 consumption with O 2 supply. Here we show that both spontaneous and activity-induced dips in tissue PO 2 drive the earliest phase of capillary hyperemia. Furthermore, PO 2 directly controls the velocity by which RBCs transit through a narrow channel in a microfluidic device. Thus, RBCs may themselves serve as autonomous regulators of capillary perfusion that operate independently of the neurovascular unit and the release of vasoactive molecules. The idea that erythrocytes-the major suppliers of O 2 -function not only as O 2 carriers but also as O 2 sensors and regulators of capillary blood flow provides a simple, yet swift and precise, mechanism for controlling the cerebral microcirculation.
EXPERIMENTAL PROCEDURES Animals
C57Bl6 mice (25-30 g, 8-12 weeks old, The Jackson Laboratory) and NG2-DsRed mice (Tg(Cspg4-DsRed.T1)1Akik/J, RRID: IMSR_JAX:008241) (Zhu et al., 2008 ) on a C57Bl6 background of either sex were utilized. Mice were prepared for in vivo imaging as described previously (Bekar et al., 2008; Ding et al., 2013; Wang et al., 2006; Xie et al., 2013) and in the Supplemental Experimental Procedures.
Physiological Manipulations and Measurements
Physiological manipulations and measurements were performed as previously described (Baek et al., 2012; Bekar et al., 2012; Kasischke et al., 2011; Takano et al., 2007; Vá zquez et al., 2011; Xie et al., 2013; Zhou et al., 2011) and in the Supplemental Experimental Procedures.
Microfluidic Device and RBC Imaging
Microfluidic device construction and human RBC imaging were performed as previously described (Duffy et al., 1998; Wan et al., 2008 Wan et al., , 2011 and in the Supplemental Experimental Procedures.
Intrinsic Optical Signal and Two-Photon Imaging Intrinsic optical signaling (IOS), two-photon imaging, and immunofluorescence imaging were performed as previously described (Armulik et al., 2011; Bekar et al., 2012) and in the Supplemental Experimental Procedures.
Statistics
All data were expressed as mean ± SEM. Normality of the data was evaluated with the Shapiro-Wilk test, and non-parametric tests were used when normality was not assumed. A Student's t test or Mann-Whitney test was used to compare two groups. A one-way ANOVA with a Bonferroni's multiple comparison test or a Kruskal-Wallis test with a Dunn's multiple comparison test was used to compare multiple groups. A paired t test or Wilcoxon matched-pairs signed-rank test was used for pairwise comparisons. p < 0.05 was considered significant. (1) Sensory input triggers local neural activation resulting in (2) a local dip in tissue and plasma O 2 tension (Parpaleix et al., 2013) . The dip in plasma O 2 tension changes the mechanical properties of RBCs resulting in (3) an increase in RBC velocity. The transient dip in O 2 tension drives the fast, initial phase of capillary hyperemia. The rise in RBC velocity in both capillaries and arterioles rapidly increases O 2 delivery, resulting in an O 2 overshoot (4 and 5). The delayed and more sustained phase of capillary hyperemia is driven by vasodilation of upstream arterioles. It is not known whether the initial phase of capillary hyperemia, which is driven by a dip in local PO 2 , is mechanistically linked to the delayed dilation of the upstream arteriole. Hypothetical pathways of signal propagation along the neurovascular unit include Ca 2+ signaling in endothelial cells, pericytes, or vascular endfeet of astrocytes. Also, it is possible that an initial increase in capillary perfusion results in pressure changes that trigger a myogenic response in the upstream arteriole. Finally, capillary hyperemia and arteriole vasodilation may be initiated independently. Several mechanisms, including release of vasoactive mediators from interneurons or astrocytes, are known to directly cause arteriole vasodilation (Cauli and Hamel, 2010; Iadecola and Nedergaard, 2007 
